Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The conspiracy of cancer prognosis

Rick Boulay, MD
Conditions
March 1, 2014
Share
Tweet
Share

It should be easy, right? I mean, I am a professional with what feels like eons of training. So how can an oncologist with years of experience fail at perhaps the most important question a patient can ask, ”How long do I have, Doc?”

It’s not that I want to avoid the question. Well, okay, sometimes I do. It’s not the most pleasant of conversations to have. But really, I don’t dodge the question. I simply don’t always have an accurate or reliable answer. And this is too important a question to merely guess at.

Prognosis is not so much “how many days do I have left?” but much more so “ how shall I spend my time?” Should I quit my job? Should I move back home to be with my family? Should I start my bucket list? Will I be able to even get to my bucket list?

There is so much is riding on this one question that the answer just can’t be wrong. I can’t be wrong. And believe it or not, there are so many assumptions that go into calculating a prognosis that I generally don’t have all the information I need to be accurate, or sometimes even in the ballpark. And the crystal ball gets a little cloudy. Please consider the following.

1. Primary site of cancer. Where a cancer began is most important in predicting its behavior and response to treatment. Sometimes this is impossible to ascertain. Did it start in the pancreas and go to the ovary? Or the other way around. These two clinical scenarios have completely different prognoses. Biopsies and microscopic patterns are generally helpful. Staining patterns of proteins in the cancer cell can be helpful. Algorithms of the staining patterns can be used to identify where the cancer began. But not always. The most important question can sometimes go unanswered.

2. Stage of cancer. How far a cancer has traveled from its original site is also very important in predicting prognosis. Did it go to the lungs, the lymph nodes, the liver? Multiple technologies can be employed in this endeavor, each with differing reliability. Surgery or biopsy is generally the most accurate but comes at a high cost of being physically well enough to undergo these procedures. Their complications can be very risky including injuring good tissue or sometimes missing the intended biopsy site giving false readings. As a result, less accurate images are often relied upon instead including the best, PET/CT scans with as high as 87% accurate in some lung cancers or as low as 20-40% accurate in early stage breast cancers. CT scanning alone fairs even less well. Physical exam alone or plain x-rays, even worse.

3. Availability of treatment. Sometimes the best treatments are unavailable for use by patients who desparately need them. Shortages of chemotherapy drugs due to multiple forces including economic have resulted in patients receiving less that optimal treatment. Clinical trials, offering cutting edge treatment, are often unavailable for uncommon cancers. Even where you live or your race or ethnicity can factor into the appropriateness of your treatment. And if you think you because you have great insurance so it should be no problem getting treatment paid for, think again. There are many cases where insurance companies have been known to deny or delay payment for proven treatment essentially removing effective treatment options.

4. Effective social support. Marriage has been shown to improve survival of cancer by 20%. Now I’m not saying that everyone with a cancer diagnosis needs to go out and get hitched. But in factoring a prognosis, how much help you get really counts. The burdens of cancer treatment are best managed as a team. Getting to treatments on time, having another set of eyes watching over a cancer patient, just being there and listening all can factor in to a better prognosis.

5. The will to live. Perhaps the least understood and unpredictable variable is a patient’s own intrinsic drive to survive. Those who strongly feel some Earthly bonds, in my opinion, often live a lot longer than expected, even in the face of advanced disease. Those with purpose or goal seem to make it beyond their goal. And those who abandon their desire can seemingly, at will, allow life to ebb.

So to accurately answer your question, I have a lot to consider. Of course it starts with a basic understanding of your disease and its survival statistics, based on site of cancer and its stage. Then you have to figure in general health, treatment availability, social support, and how much you really want to live. And, oh yeah, there are always those 5% outliers, on the edges of the survival curves who do either way better, or worse than expected without any rationale at all. Finally, as people who happen to be physicians, we must factor in our own personal biases. Am I a glass half empty or glass half full person, do I tend to overestimate or underestimate?

I generally think along two lines: curability and palliative treatment. If the disease is potentially curable I’ll say “ based on your disease and its stage you have a ___% cure rate.” If the treatment available will not cure your disease, I guestimate a survival time of weeks, months or years based on available data and if I think you may adhere to, or vary from it. Then I make sure my assumptions are valid by going over them with you.

I think that gets to heart of what you’re asking me. And I strongly believe you have the right to know. My colleagues feel the same. We should all be able to plan our futures. I just hate it when I’m wrong. And I am wrong more often than I care to admit. And therein lies the angst.

Rick Boulay is a gynecologic oncologist who blogs at Journey Through Cancer.

ADVERTISEMENT

Prev

How we doubled colorectal cancer screening rates

March 1, 2014 Kevin 1
…
Next

What is the price of that medical test?

March 1, 2014 Kevin 7
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
How we doubled colorectal cancer screening rates
Next Post >
What is the price of that medical test?

ADVERTISEMENT

More by Rick Boulay, MD

  • Dear insurance doctor: You are not my peer

    Rick Boulay, MD
  • Cancerism and the harms of our negative cancer bias

    Rick Boulay, MD
  • a desk with keyboard and ipad with the kevinmd logo

    A frequent witness to the power of faith

    Rick Boulay, MD

More in Conditions

  • Why Hollywood’s allergy jokes are dangerous

    Lianne Mandelbaum, PT
  • Coconut oil’s role in Alzheimer’s and depression

    Marc Arginteanu, MD
  • Ancient health secrets for modern life

    Larry Kaskel, MD
  • How the internet broke the doctor-parent trust

    Wendy L. Hunter, MD
  • Mpox isn’t over: A silent epidemic is growing

    Melvin Sanicas, MD
  • How your family system secretly shapes your health

    Su Yeong Kim, PhD
  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • Why doctors struggle with family caregiving and how to find grace [PODCAST]

      The Podcast by KevinMD | Podcast
    • Locum tenens: Reclaiming purpose, autonomy, and financial freedom in medicine

      Trevor Cabrera, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
  • Recent Posts

    • How trust and communication power successful dyad leadership in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why Hollywood’s allergy jokes are dangerous

      Lianne Mandelbaum, PT | Conditions
    • How I learned to love my unique name as a doctor

      Zoran Naumovski, MD | Physician
    • My first week on night float as a medical student

      Amish Jain | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
    • Creating safe, authentic group experiences

      Diane W. Shannon, MD, MPH | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • Why doctors struggle with family caregiving and how to find grace [PODCAST]

      The Podcast by KevinMD | Podcast
    • Locum tenens: Reclaiming purpose, autonomy, and financial freedom in medicine

      Trevor Cabrera, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
  • Recent Posts

    • How trust and communication power successful dyad leadership in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why Hollywood’s allergy jokes are dangerous

      Lianne Mandelbaum, PT | Conditions
    • How I learned to love my unique name as a doctor

      Zoran Naumovski, MD | Physician
    • My first week on night float as a medical student

      Amish Jain | Education
    • What Beauty and the Beast taught me about risk

      Jayson Greenberg, MD | Physician
    • Creating safe, authentic group experiences

      Diane W. Shannon, MD, MPH | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The conspiracy of cancer prognosis
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...